Docuniv
Medical Reading

Articles

Published doctor content from the Docuniv editorial system, organized for mobile reading and quick clinical review.

Preview first. Sign in for full reading. Preview the topic first, then sign in to continue reading and use the tutor.
Articles

Early Identification and Management of Type 2 Diabetes in Primary Care

Type 2 diabetes is silent for years. Opportunistic screening, prompt confirmation and early intensive management in primary care reduce long-term complications and, for some, ca...

Docuniv Editorial 17 Nov 2026
✓ Content reviewer: Baishali
Read preview
Articles

Semaglutide in Type 2 Diabetes: Lessons from the SUSTAIN and PIONEER Programmes

SUSTAIN (injectable) and PIONEER (oral) programmes established semaglutide as a potent glucose- and weight-lowering agent with cardiovascular safety, and cardiovascular benefit ...

Docuniv Editorial 17 Nov 2026
✓ Content reviewer: Baishali
Read preview
Articles

Semaglutide versus Tirzepatide for Obesity and Type 2 Diabetes: Interpreting SURMOUNT-5

SURMOUNT-5, the first randomised head-to-head trial in obesity, showed greater weight loss with tirzepatide than semaglutide over 72 weeks. Earlier diabetes data (SURPASS-2) poi...

Docuniv Editorial 17 Nov 2026
✓ Content reviewer: Baishali
Read preview
Articles

Kidney Protection with GLP-1 Receptor Agonists: FLOW Trial Evidence in Type 2 Diabetes with CKD

FLOW showed that once-weekly semaglutide 1.0 mg reduced major kidney events by 24% in people with type 2 diabetes and chronic kidney disease (CKD), on top of standard care. It w...

Docuniv Editorial 17 Nov 2026
✓ Content reviewer: Suja
Read preview
Articles

GLP-1 Receptor Agonist Safety: Retinopathy, Psychiatric Signals and Perioperative Guidance

GLP-1 receptor agonists are generally well tolerated, but concerns regarding diabetic retinopathy, optic neuropathy, psychiatric effects and aspiration risk during anaesthesia w...

Docuniv Editorial 17 Nov 2026
✓ Content reviewer: Suja
Read preview
Live tutor
Ask a clinical question right now.

Type a question about medicines, diet, symptoms, cases, algorithms, guidelines, or conference updates.

I am ready. Ask about medicines, diets, diabetes, case reasoning, conference highlights, guidelines, or algorithms.
Enter to ask · Shift+Enter for new line